EBITDA-Linked Stock Option Scheme with Phased Vesting
First written in FY2017-Q2. 12 of 17 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2022.
28 other companies' latest entry also says "Achieved".
- FY2022AchievedAnnual report
「As all stock acquisition rights under the stock option plan were exercised during the fiscal year, there was no balance at the end of the fiscal year in either the number of stock acquisition rights (rights) or the number of underlying shares (shares).」
All First and Second Series of stock acquisition rights were exercised during FY2022, leaving a zero balance of stock acquisition rights at year-end. - FY2021AdvancedAnnual report
「The average share price at the time of exercise of stock options exercised during the fiscal year ended February 2021 was ¥14,097.」
During FY2021, rights representing 7,480 shares under the First Series and 12,940 shares under the Second Series of stock acquisition rights were exercised, leaving 12,080 shares and 28,800 shares, respectively, outstanding and unexercised at year-end. - FY2020AdvancedAnnual report
「Accordingly, all of the First Series of stock acquisition rights vested.」
The First Series of stock acquisition rights fully vested upon the fourth vesting on 31 May 2019. In addition, during the fiscal year, rights representing 17,960 shares under the First Series and 42,320 shares under the Second Series were exercised, leaving 19,560 shares and 41,740 shares, respectively, outstanding and unexercised at year-end. - FY2020-Q3AdvancedAnnual report
「One director exercised stock acquisition rights, involving a transaction amount of ¥15 million.」
The exercise of stock acquisition rights by 1 director took place during the nine-month period ended the third quarter, indicating that exercise under the plan was progressing. - FY2020-Q2AdvancedAnnual report
「One director exercised stock acquisition rights, involving a transaction amount of ¥15 million.」
The exercise of stock acquisition rights by 1 director was disclosed for the six-month period ended the second quarter, indicating that exercise under the plan was progressing. - FY2020-Q1AdvancedAnnual report
「Upon the fourth vesting of the First Series of stock acquisition rights on 31 May 2019, 990 rights vested out of 2,684 rights subject to vesting (representing 19,800 shares underlying the stock acquisition rights out of 53,680 shares). As a result, 1,694 rights did not vest (representing 33,880 underlying shares). Accordingly, all of the First Series of stock acquisition rights vested.」
The First Series of stock acquisition rights fully vested upon the fourth vesting on 31 May 2019. Rights representing 84,060 shares under the Second Series remained outstanding and unexercised. - FY2019AdvancedAnnual report
「The average share price at the time of exercise of stock options exercised during the fiscal year ended February 2019 was ¥3,130.」
During the fiscal year, rights representing 15,040 shares under the First Series and 6,000 shares under the Second Series of stock acquisition rights were exercised, leaving 17,720 shares and 84,060 shares, respectively, outstanding and unexercised at year-end. - FY2019-Q3AdvancedAnnual report
「The average share price at the time of exercise of stock options exercised during the period was ¥3,067.」
Rights representing 7,160 shares under the First Series of stock acquisition rights were exercised during the period, leaving 25,600 shares outstanding as of 30 November 2018. The balance under the Second Series of stock acquisition rights was 90,060 shares. - FY2019-Q2RestatedAnnual report
「Upon the third vesting of the First Series of stock acquisition rights on 31 May 2018, 987 rights vested out of 2,662 rights subject to vesting (representing 19,740 shares underlying the stock acquisition rights out of 53,240 shares). As a result, 1,675 rights did not vest (representing 33,500 underlying shares).」
The results of the third vesting, the number of shares that did not vest and the balance, including exercised rights, continued to be disclosed. This was a restatement of the results reported in the previous quarter, not a new vesting event. - FY2019-Q1AdvancedAnnual report
「Upon the third vesting of the First Series of stock acquisition rights on 31 May 2018, 987 rights vested out of 2,662 rights subject to vesting (representing 19,740 shares underlying the stock acquisition rights out of 53,240 shares). As a result, 1,675 rights did not vest (representing 33,500 underlying shares).」
The third vesting took place on 31 May 2018, with rights representing 19,740 shares vesting under the First Series of stock acquisition rights and rights representing 33,500 shares not vesting. - FY2018AdvancedAnnual report
「During the fiscal year, treasury stock increased by ¥772.928 million, including purchases of less-than-one-unit shares, and decreased by ¥379.474 million as treasury stock was disposed of upon the exercise of stock acquisition rights. Treasury stock at the end of the fiscal year was ¥393.454 million, representing 203,643 shares.」
Exercise of the vested stock acquisition rights progressed, and 196,440 treasury shares were disposed of upon exercise during the fiscal year. Of the Second Series of stock acquisition rights, 149,200 shares were exercised, leaving 90,060 shares outstanding and unexercised. - FY2018-Q3AdvancedAnnual report
「In addition, Sunrise Capital Ⅱ, L.P., Sunrise Capital Ⅱ (Non-U.S.), L.P. and Sunrise Capital Ⅱ (JPY), L.P. transferred their holdings of the company's shares to third parties on 30 October 2017, resulting in all of the remaining 5,993 rights (representing 119,860 underlying shares) vesting on 31 October 2017.」
Following the shareholders' transfer of the company's shares to third parties, all of the remaining 5,993 rights under the Second Series of stock acquisition rights, representing 119,860 shares, vested on 31 October 2017. - FY2018-Q2RestatedAnnual report
「Upon the second vesting of the First Series of stock acquisition rights on 31 May 2017, 1,097 rights vested out of 2,985 rights subject to vesting (representing 21,940 shares underlying the stock acquisition rights out of 59,700 shares). As a result, 1,888 rights did not vest (representing 37,760 underlying shares). Upon the second vesting of the Second Series of stock acquisition rights on 31 May 2017, 2,985 rights vested (representing 59,700 underlying shares).」
The results of the second vesting and the status of the stock acquisition rights, including the unvested balance, continued to be disclosed. - FY2018-Q1AdvancedAnnual report
「Upon the second vesting of the First Series of stock acquisition rights on 31 May 2017, 1,097 rights vested out of 2,985 rights subject to vesting (representing 21,940 shares underlying the stock acquisition rights out of 59,700 shares). As a result, 1,888 rights did not vest (representing 37,760 underlying shares). Upon the second vesting of the Second Series of stock acquisition rights on 31 May 2017, 2,985 rights vested (representing 59,700 underlying shares).」
The second vesting took place on 31 May 2017, and specific vesting results were disclosed for the First and Second Series of stock acquisition rights. - FY2017RestatedAnnual report
「Vesting schedule: first vesting, 31 May 2016, 25%; second vesting, 31 May 2017, 25%; third vesting, 31 May 2018, 25%; fourth vesting, 31 May 2019, 25% The formula for the number of these stock acquisition rights to vest is as follows. Number of stock acquisition rights to vest = Number subject to vesting × EBITDA / Target EBITDA」
The four-stage vesting schedule, the EBITDA-linked formula and the results of the first vesting continued to be disclosed in the annual filing. - FY2017-Q3RestatedAnnual report
「Upon the first vesting of the First Series of stock acquisition rights, 2,434 rights vested out of 3,793 rights subject to vesting (representing 48,680 shares underlying the stock acquisition rights out of 75,860 shares).」
The staged vesting and EBITDA-linked structure, together with the results of the first vesting, continued to be disclosed. - FY2017-Q2AdvancedAnnual report
「The formula for the number of these stock acquisition rights to vest is as follows. Number of stock acquisition rights to vest = Number subject to vesting × EBITDA / Target EBITDA」
Vesting dates were set at 25% each from 31 May 2016 through 31 May 2019, and the results of the first vesting for the First and Second Series of stock acquisition rights were also disclosed.